🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, Open-Label, Adaptive Study of Novel GS-9973 Tablet Formu...
Status
Completed
Location
Investigational Site
Start Date
2013-05
Trial ID
NCT01841489
This is a randomized, observer-blinded, Phase 2 study evaluating the safety...
Status
Completed
Location
Paratus Clinical Research - Canberra
Start Date
2022-12-30
Trial ID
NCT05519839
Antipsychotic medications are widely used to treat schizophrenia but may ca...
Status
Not Yet Recruiting
Location
Shanghai Mental Health Center
Start Date
2026-10-01
Trial ID
NCT07767526
Treatments Being Tested
A randomized, double-blinded, single/multiple dosing, dose escalation Phase...
Status
Recruiting
Location
Chungbuk National University Hospital
Start Date
2025-09-11
Trial ID
NCT07282145
This is a safety and tolerability study investigating the effect of an amin...
Status
Completed
Location
McMaster Univeristy
Start Date
2017-08-30
Trial ID
NCT03267745
Treatments Being Tested
The objective of the study is to evaluate the long-term safety and tolerabi...
Status
Completed
Location
Birmingham Gastroenterology Associates, PC
Start Date
2006-10
Trial ID
NCT00486031
Treatments Being Tested
Crohn's disease is a chronic and complex inflammatory bowel disease affecti...
Status
Recruiting
Location
CHU Liege - Gastroenterology
Start Date
2024-03-12
Trial ID
NCT06104631
The purpose of this study is to assess the rate and extent of absorption of...
Status
Completed
Location
SGS Life Science Services
Start Date
2019-09-16
Trial ID
NCT04087759
Treatments Being Tested
The primary objective of the study is to investigate the safety and tolerab...
Status
Completed
Location
Research Site
Start Date
2008-10
Trial ID
NCT00772759
Treatments Being Tested
To main objective is to evaluate the safety, tolerability, and pharmacokine...
Status
Completed
Location
Jiangnan University Affiliated Hospital
Start Date
2025-05-17
Trial ID
NCT07007546